Examples of 'non-peptide' in a sentence
Meaning of "non-peptide"
Non-peptide (noun): Referring to a substance or molecule that does not consist of linked amino acid units, commonly used in the context of biochemistry and pharmaceuticals
How to use "non-peptide" in a sentence
Basic
Advanced
non-peptide
Of particular interest are non-peptide combinatorial libraries.
The synthetic compound is preferably a non-peptide.
Also non-peptide building blocks can be used.
Linkers may also be non-peptide molecules.
Non-peptide vasopressin antagonists have recently been disclosed.
These are peptide and non-peptide compounds.
Non-peptide mimetics of peptides are discussed further below.
An amylin antagonist may be a peptide or non-peptide compound.
One or more of the non-peptide or peptide linkers are optional.
A calcitonin agonist may be a peptide or non-peptide compound.
Another type of non-peptide linker is a polyethylene glycol group.
The peptides may include non-peptide bonds.
The multiplicity of non-peptide compounds are attached to a solid support.
An amylin agonist may be a peptide or a non-peptide compound.
In a preferred embodiment, the non-peptide compounds of the library are peptidomimetics.
See also
Such a linker molecule can be a peptide linker or a non-peptide linker.
Intermediates for preparating non-peptide retroviral protease inhibitors.
The fusión molecule may comprise a synthetic non-peptide linker.
It is for this reason that non-peptide tachykinin antagonists are sought.
Such properties are most likely to be obtained with a non-peptide compound.
These non-peptide compounds contained unnatural amino acids at 3 or more positions.
Such analogs may be peptide or non-peptide analogs.
These are the only non-peptide matrix metalloproteinase inhibitors disclosed to date.
The peptide may also have non-peptide bonds.
Non-peptide ligands have been developed for each of the tachykinin receptors.
The peptides may also have non-peptide bonds.
Non-peptide mimetics of the peptides of the present invention are also described.
The linker includes peptide and non-peptide linkers.
Whether non-peptide components of the mixture contribute to the biological activity is unknown.
Libraries can be synthesized of peptoids and non-peptide synthetic moieties.
The non-peptide compounds of the library are designed to mimic the peptide motif.
The one or more candidate molecules may be a peptide or a non-peptide.
One or more non-peptide compounds that bind to the target are thereby selected.
They used infrared thermography to identify catalysts in non-peptide tethered libraries.
The secondary antibody or non-peptide binding pair can then be linked to a label.
Libraries further can be synthesized of peptides and non-peptide synthetic moieties.
Other non-peptide neuropeptide-Y antagonist species have been developed for pharmacologic use.
Once an effective peptide inhibitor is described a non-peptide drug can be developed.
Non-peptide linkers include chemical cross linking agents and polyethylene glycol.
In essence, this invention provides a class of potent non-peptide tachykinin antagonists.
Peptidomimetic refers to non-peptide molecules that mimic the binding characteristics of peptides.
Additional components associated with amyloid plaques include non-peptide components.
Non-peptide compounds that interacted with the target were recovered and were analyzed.
Such a binding site may be capable of binding to peptides or non-peptide moieties.
More particularly, it relates to non-peptide GnRH antagonists or agonists and to their preparation.
Thus, the invention relates to extremely useful compounds as non-peptide compounds.
It may also be possible to include non-peptide linkages and other chemical modifications.
The linkers of the present invention may also be non-peptide linkers.
Selected non-peptide compounds were eluted with acetic acid and dried by lyophilization.
Similar applications would be open to the non-peptide agonists of the present invention.
